Skip to content

Author

E. Ciruelos

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Germline pharmacogenetic variants associated with trastuzumab deruxtecan-induced interstitial lung disease in advanced breast cancer: PROCURE project

Background Trastuzumab deruxtecan (T-DXd) has demonstrated substantial clinical benefit in patients with advanced human epidermal growth factor receptor 2 (HER2)-positive and HER2-low breast cancer. However, treatment-related adverse events—particularly interstitial lung disease (ILD) or pneumonitis—represent a clinica...

A. Arenas, C. Saura, M. Alva Bianchi et al. · 0 citations
Review Open access Oct 2026

To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission

Introduction HER2-targeted therapy (HER2-TT) has improved outcomes in HER2+ metastatic breast cancer (MBC) with increasing numbers of long-term survivors in complete response (CR). Little is known about discontinuing maintenance HER2-TT in these patients. Methods An online survey of physicians was conducted via the Bre...

Han-Yi Lee, W. Ong, V. Tjan-Heijnen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.